25mg IG226 Pill - white capsule/oblong, 15mm
Pill with imprint 25mg IG226 is White, Capsule/Oblong and has been identified as Zonisamide 25 mg. It is supplied by Cipla USA, Inc.
Zonisamide is used in the treatment of Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 25mg IG226
Zonisamide
- Imprint
- 25mg IG226
- Strength
- 25 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- Manufacturer
- InvaGen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 76282-0226
- Inactive Ingredients
-
microcrystalline cellulose,
hydrogenated castor oil,
gelatin,
titanium dioxide
Note: Inactive ingredients may vary.
More about zonisamide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (145)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
